Themis Medicare Limited

Themis Medicare Ltd. Publishes Newspaper Ads for 56th AGM and e-Voting

Themis Medicare Limited announced its 56th Annual General Meeting (AGM) through newspaper advertisements published on September 8, 2026. Information regarding remote e-voting and book closure was also provided.

Themis Medicare Announces 56th AGM on Sep 30, 2026, to Adopt FY26 Audited Results

Themis Medicare Limited will hold its 56th AGM on September 30, 2026, to approve FY26 financial results. FY26 consolidated revenue was ₹342.24 crore (down from ₹405.51 crore in FY25). Q4 FY26 revenue grew 6.7% YoY to ₹76.5 crore, with PAT at ₹8.9 crore.

Themis Medicare Clarifies No Material Information Driving Volume Spurt

Themis Medicare Limited clarified to BSE and NSE that no material information is pending or delayed, explaining the recent spurt in its stock volume. The company confirmed adherence to SEBI disclosure regulations and timely dissemination of information.

Themis Medicare: Updates Company Secretary Email ID & RTA Contact

Themis Medicare Limited is updating its Company Secretary's email to suresh.savaliya@themismedicare.com. The RTA's email is also updated to investor.helpdesk@in.mpms.mufg.com. These changes are for investor communication and record updates.

Themis Medicare Publishes Unaudited Financial Results for Q1 FY27

Themis Medicare Limited published its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The results were advertised in the Indian Express and Financials Express on August 14, 2026, and are also available on the company website.

Themis Medicare Appoints Suresh Savaliya as Company Secretary; Approves Q1 FY27 Results

Themis Medicare Limited's Board approved Q1 FY27 Un-Audited Standalone and Consolidated Financial Results. The Board accepted the resignation of Mr. Nagraj Mogaveera as Interim Company Secretary & Compliance Officer and appointed Mr. Suresh Savaliya as the new Company Secretary, Compliance Officer, and KMP, both effective August 13, 2026.

Themis Medicare Ltd: Certificate Under SEBI (Depositories) Regs, 2018 For Q1FY27

Themis Medicare Limited received a certificate for Q1FY27 from its RTA, MUFG Intime India Pvt. Ltd. The certificate confirms compliance with SEBI (Depositories and Participants) Regulations, 2018, regarding dematerialisation of securities.

Themis Medicare Clarifies No Material Information Driving Price Surge

Themis Medicare Limited clarified to the stock exchange that there is no undisclosed material information causing the recent surge in its stock volume. The company confirmed adherence to SEBI regulations for timely disclosures.

Themis Medicare Announces Newspaper Publication of Audited Financial Results

Themis Medicare Limited published its audited standalone and consolidated financial results for the quarter and financial year ending March 31, 2026. The results were advertised on May 29, 2026, in 'Indian Express' and 'Financial Express'. Full details are available via QR code, weblink, and the company website.

Themis Medicare Q4 FY26: Revenue Up 6.7% to ₹76.5 Cr, PAT Turns Positive

Themis Medicare reported Q4 FY26 consolidated revenue of ₹76.5 crore, up 6.7% YoY. PAT turned positive at ₹8.9 crore from a loss of ₹9.7 crore. For FY26, revenue was ₹342.2 crore. The company is focusing on operational efficiencies and cost optimization to drive future growth.

Themis Medicare Board Approves FY26 Results and Recommends 50% Dividend

Themis Medicare Limited approved audited standalone and consolidated financial results for FY26. Recommended a final dividend of Re. 0.50 per equity share. Appointed M/s. R. Nanabhoy & Co. as Cost Auditor for FY27.

Themis Medicare Submits Valuation Report for Preferential Allotment of Warrants

Themis Medicare Limited submitted a valuation report and updated compliance certificate for preferential allotment of convertible warrants. This follows Board approval on February 13, 2026, and addresses queries from stock exchanges.

Themis Medicare Publishes Notice on Share Transfer and Dematerialisation

Themis Medicare Limited has published a notice regarding a special window for re-lodging transfer requests and dematerialising physical shares. This was published in the Financial Express and The Indian Express on April 8, 2026, as per SEBI guidelines.

Themis Medicare Promoters Declare No Share Encumbrance for FY26

Themis Medicare promoters, including Dr. Dinesh S. Patel, declared no share encumbrance for FY26 under SEBI Takeover Regulations. Previous pledges by VIVIDHMARGI INVESTMENTS PRIVATE LIMITED in FY24 were already disclosed.

Themis Medicare Ltd: Certificate Under SEBI Reg 74(5) For Q4 FY26

Themis Medicare Limited received a certificate under SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended March 31, 2026. The Registrar and Share Transfer Agent confirmed processing of dematerialized securities.

Themis Medicare shareholders approve related party transactions and warrant issuance via postal ballot.

Themis Medicare Limited shareholders approved four resolutions via postal ballot. These include related party transactions with Themis Distributors, Vividhmargi Investments, Gujarat Themis Biosyn, and Dr. Sachin D. Patel (up to ₹130 crore). A special resolution also passed for issuing convertible warrants to Vividhmargi Investments on a preferential basis.

Themis Medicare: Vividhmargi Investments Acquires 10.75% Stake via Amalgamation

Vividhmargi Investments Private Limited (VMIPL) has increased its stake in Themis Medicare Limited to 26.52% following an amalgamation. This follows the vesting of shares from Vividh Distributors Private Limited and Themis Distributors Private Limited into VMIPL on March 24, 2026. VMIPL's shareholding increased by 10.75%.

Themis Medicare Receives Income Tax Notice for ₹13.32 Crore Demand

Themis Medicare Limited received a notice from the Income Tax Department for outstanding tax demands totaling approximately ₹13.32 crore for assessment years 2017-18, 2018-19, and 2020-21. The company is preparing to file an appeal and believes the matter will not adversely impact its financial operations.

Gujarat Themis Biosyn Closes Trading Window from April 1st for Q4 FY26 Results

Gujarat Themis Biosyn Limited will close its trading window from April 1st, 2026. The window will reopen 48 hours after the declaration of audited financial results for the quarter ending March 31st, 2026.

Themis Medicare Limited: Trading Window Closes April 1, 2026 for Q4 FY26 Results

Themis Medicare Limited will close its trading window from April 1, 2026. The window will reopen 48 hours after the declaration of audited financial results for the quarter ending March 31, 2026. The board meeting date for considering these results will be announced later.

Themis Medicare Limited Publishes Newspaper Advertisement for Postal Ballot Corrigendum

Themis Medicare Limited has published a Corrigendum to its Notice of Postal Ballot dated February 25, 2026. The advertisement appeared in the Indian Express (English) and Financial Express (Gujarati) newspapers on March 11, 2026. Copies of the published articles have been filed with the stock exchanges.

Themis Medicare Issues Corrigendum for Preferential Warrants, Adjusts Terms

Themis Medicare Limited issued a corrigendum for its preferential warrant issuance to VMIPL. The Warrants Issue Price is revised to ₹102.87 (premium ₹101.87), increasing the total issue size to ₹47.28 crore. Initial payment is 25% (₹11.82 crore), with the balance due upon exercise. The corrigendum clarifies terms and compliance details.

Themis Medicare revises preferential issue price to ₹102.87 per warrant

Themis Medicare Limited's Preferential Issue Committee revised the issue price for Convertible Equity Warrants to ₹102.87, up from ₹100. The allotment is to Vividhmargi Investments Private Limited and is subject to shareholder and exchange approvals.

Themis Medicare Limited: Newspaper Advertisement for Postal Ballot Notice

Themis Medicare Limited published a newspaper advertisement on February 26, 2026, announcing the Notice of Postal Ballot. This is in compliance with SEBI Listing Regulations.

Themis Medicare Approves Preferential Issue of 45.95 Lakh Warrants at ₹100

Themis Medicare Limited's Preferential Issue Committee approved the issuance of 45,95,795 Convertible Equity Warrants to Vividhmargi Investments Private Limited at ₹100 per warrant. E-voting and postal ballot for shareholder approval will be held from February 26, 2026, to March 27, 2026.

Themis Medicare Seeks Shareholder Approval for Related Party Transactions and Warrant Issuance

Themis Medicare Limited is seeking shareholder approval via postal ballot for related party transactions totaling ₹250 Crore with TDPL/VMIPL and ₹50 Crore with GTBL for FY 2026-27. It also proposes an inter-se share transfer of GTBL for up to ₹130 Crore and a preferential issuance of convertible warrants worth ₹45.96 Crore to a promoter group company. E-voting is from Feb 26 to Mar 27, 2026.

Themis Medicare publishes Q3 FY26 Un-Audited Financial Results

Themis Medicare Limited published its un-audited standalone and consolidated financial results for Q3 FY26 and the nine months ended December 31, 2025. The results were advertised in the Indian Express and Financial Express on February 14, 2026.

Themis Medicare Limited Announces Resignation of Company Secretary & KMP

Mr. Pradeep M. Chandan has resigned as Company Secretary, Compliance Officer, and KMP of Themis Medicare Limited, citing other professional commitments. His resignation is effective February 13, 2026.

Themis Medicare Appoints Nagraj Mogaveera as Interim Company Secretary

Themis Medicare Limited's Board approved financial results for Q3 FY26. Mr. Pradeep M. Chandan resigned as Company Secretary, and Mr. Nagraj Mogaveera was appointed as Interim Company Secretary. The company also approved issuing convertible warrants to promoters and an inter-se transfer of shares in Gujarat Themis Biosyn Limited.

Themis Medicare Board Approves Q3 Results, Appoints Interim CS, Plans Preferential Issue

Themis Medicare reported its Q3 FY26 results. The Board approved the resignation of Company Secretary Mr. Pradeep M. Chandan and appointed Mr. Nagraj Mogaveera as interim CS. The company also approved a preferential issue of convertible equity warrants to promoters, potentially up to 4.99% of shareholding.

Themis Medicare Q3 FY26: Revenue ₹90 Cr, EBITDA ₹9.8 Cr, PAT ₹10 Cr

Themis Medicare reported Q3 FY26 revenue of ₹90.13 crore, down 3.9% YoY. EBITDA rose 14.9% to ₹9.80 crore, with margins improving to 10.87%. PAT surged to ₹10.09 crore from ₹0.52 crore in Q3 FY25. The API business doubled YoY, offsetting formulation sluggishness. The company aims to lead in the hospital business.

Themis Medicare Approves Financial Results, Warrant Issue, and Key Management Changes

Themis Medicare Limited reported its Q3 FY26 results. The Board approved the issuance of convertible equity warrants to promoters, potentially up to 4.99% of share capital. Mr. Pradeep M. Chandan resigned as Company Secretary, and Mr. Nagraj Mogaveera was appointed as Interim Company Secretary. An inter-se transfer of 3% in Gujarat Themis Biosyn Limited was also approved.

Themis Medicare Board Approves Financial Results, Equity Warrants, and Key Appointments

Themis Medicare Limited's Board approved Q3 FY26 financial results. The company also approved the issuance of convertible equity warrants to promoters and appointed Mr. Nagraj Mogaveera as Interim Company Secretary. Mr. Pradeep M. Chandan resigned from his position.

Themis Medicare: No Physical Share Transfer Requests in December 2025

Themis Medicare Limited reported no physical share transfer re-lodgement requests for December 2025. This aligns with SEBI's 'Ease of Doing Investment' initiative. The RTA, MUFG Intime India Private Limited, confirmed the nil receipt.

Themis Medicare Files SEBI Compliance Certificate for Q3 FY26

Themis Medicare Limited submitted a certificate for the quarter ended December 31, 2025, under SEBI (Depositories and Participants) Regulations, 2018. The Registrar and Share Transfer Agent confirmed the dematerialisation and processing of securities.

Themis Medicare: Reminder Issued for Re-lodgement of Physical Share Transfer Requests

Themis Medicare Limited published a reminder about a special window for re-lodging physical share transfer requests. This notice, published on December 30, 2025, follows SEBI guidelines and is available on the company's website.

Themis Medicare: No Physical Share Transfer Requests Re-lodged in Oct-Nov 2025

Themis Medicare Limited reported no re-lodgement of physical share transfer requests for October and November 2025, as per SEBI's special window. This confirmation was provided by their RTA, MUFG Intime India Private Limited.

Themis Medicare Limited Closes Trading Window from Jan 1, 2026

Themis Medicare Limited will close its trading window from January 1, 2026. The window will reopen 48 hours after the declaration of financial results for the quarter ending December 31, 2025. The Board Meeting date for this purpose will be announced later.

Themis Medicare: Newspaper Publication of Unaudited Financial Results

Themis Medicare Limited publicized unaudited financial results for the quarter and half year ended September 30, 2025, in compliance with SEBI regulations, as announced on November 14, 2025.

Themis Medicare Limited Announces Investor Presentation

Themis Medicare Limited submitted its Investor Presentation. Consolidated revenue for the quarter was ₹78 crore.The company expects a positive development by March 2026.

Themis Medicare Reports Q2 Loss, Withdraws GTBL Merger Scheme

Themis Medicare reported significant losses for Q2 FY26 in both standalone and consolidated results, with revenue declining. The company also withdrew its merger scheme with Gujarat Themis Biosyn Limited and initiated the dissolution of a UK subsidiary.

Themis Medicare Limited Approves Un-Audited Results for Quarter Ended Sep 2025

Themis Medicare Limited's board approves unaudited standalone and consolidated financial results for the quarter ended September 30, 2025. Standalone revenue is ₹7,799.41 Lakhs with a loss of ₹535.55 Lakhs. The board also resolved to withdraw the amalgamation scheme.

Change in Director(s) at Themis Medicare Limited

Ms. Manjul Sandhu completed her term as Independent Woman Director of Themis Medicare Limited on November 10, 2025.

Report on Special Window for Re-lodgement of Physical Shares

Themis Medicare Limited reports no re-lodgement requests for physical share transfers in July-September 2025, complying with SEBI circular.

Newspaper Publication: Reminder for Re-lodgement of Physical Share Transfer Requests

Themis Medicare Limited publicized a reminder in newspapers regarding the special window for re-lodgement of physical share transfer requests, following their earlier intimation and SEBI circular.

Themis Medicare files SEBI compliance certificate for half year ended Sep 30, 2025

Themis Medicare Limited filed a certificate under SEBI (Depositories and Participants) Regulations, 2018, for the half year ended September 30, 2025, confirming proper dematerialization processes.

Themis Medicare Launches 'Saksham Niveshak' Campaign

Themis Medicare Limited launched the "Saksham Niveshak" campaign to facilitate shareholders in claiming unpaid dividends and updating KYC details, in response to the IEPFA initiative.

Themis Medicare Approves ₹0.50 Dividend, Appoints New Independent Director and Secretarial Auditor

Themis Medicare Announces 55th AGM on September 12, 2025

Themis Medicare Q1 FY26 Revenue at ₹98 Crore; API Business Shows Strong Recovery